Neuropharmacology and Neurochemistry
Neuropharmacology is the study of how drugs alter the cellular functions of the nervous system and the neuronal mechanisms by which they inhibit behavior. There are two main branches of neuropharmacology: behavioral and molecular pharmacology. Behavioral neuropharmacology focuses on the study of the effects of drugs on human behavior (neuropsychopharmacology), including the study of the effects of drug dependence and addiction on the human brain. Molecular neuropharmacology involves the study of neurons. Neurochemistry is the science of chemicals involving neurotransmitters and other molecules such as psychotropic drugs and neuropeptides that control and affect the physiology of the nervous system.
- Neurotransmitter Systems and Signaling Pathways
- Neuromodulation and Neuroplasticity
- Neurochemistry of Neurodegenerative Diseases
Related Conference of Neuropharmacology and Neurochemistry
21th International Conference on Allergic Diseases and Clinical Immunology
13th World Congress and Exhibition on Antibiotics and Antibiotic Resistance
Neuropharmacology and Neurochemistry Conference Speakers
Recommended Sessions
- Alzheimers and Parkinsons Diseases
- Behavioral Neuroscience
- Brain Injury
- Brain Pathology and Oncology Research
- Brain Stimulation and Imaging
- Clinical and Translational Neurology
- Clinical Neurophysiology
- Cognitive Neuroscience and Psychology
- Molecular Genetics and Neurobiology
- Neurodegenerative Diseases:
- Neurodermatology
- Neurogenesis
- Neuroinformatics and Computational Neuroscience
- Neurological Disorders
- Neurological Infections
- Neuropharmacology and Neurochemistry
- Neuropsychology and Addiction
- Neuroscience and Artificial Intelligence
- Neurosurgery and Spine
- Ophthalmology and Visual Neuroscience
- Paediatric Neurology
- Stem Cells Role in Neuro-Biological Treatment
Related Journals
Are you interested in
- Antibiotic Prophylaxis - Antibiotics 2026 (UK)
- Antibiotic Resistance: Opportunities and Challenges - Antibiotics 2026 (UK)
- Antibiotic-resistant Bacterial infections - Antibiotics 2026 (UK)
- Antibiotics - Antibiotics 2026 (UK)
- Antibiotics for Various Diseases and Infections - Antibiotics 2026 (UK)
- Antibiotics: In Pregnancy and Lactation - Antibiotics 2026 (UK)
- Antimicrobial Peptides - Antibiotics 2026 (UK)
- Antimicrobial Therapy - Antibiotics 2026 (UK)
- Clinical Trials of Antibiotics - Antibiotics 2026 (UK)
- Current Research in Antibiotic Resistance - Antibiotics 2026 (UK)
- Developing Alternatives to Antibiotics - Antibiotics 2026 (UK)
- Drug Discovery and Novel Delivery Technologies - Antibiotics 2026 (UK)
- Immunology & Vaccines - Antibiotics 2026 (UK)
- Infectious Diseases - Antibiotics 2026 (UK)
- Mechanisms and Evolution of Antibiotic Resistance - Antibiotics 2026 (UK)
- Micro Organisms in Recent Drug Discovery - Antibiotics 2026 (UK)
- Microorganisms Producing Antibiotics - Antibiotics 2026 (UK)
- Modern Antibiotics for Various Diseases and Infections - Antibiotics 2026 (UK)
- New antibiotics and non-antibiotic approaches - Antibiotics 2026 (UK)
- Pharmacokinetics and Pharmacodynamics of Antimicrobial Drugs - Antibiotics 2026 (UK)
- Pharmacology & Toxicology - Antibiotics 2026 (UK)
- Prevention and Control of Antibiotic Resistance - Antibiotics 2026 (UK)
- The Next Generation Approach of Antibiotics - Antibiotics 2026 (UK)

